Assume incorrectly for those of us that are in it from conception, well for myself at least. It was adapt first and foremost. The vaccine business, whilst briefly exciting, was an example of the old management's diworsification. There would be no DurAVR without those that initially invested in Adapt.
Ann: FDA Approves Early Feasibility Study for DurAVR THV System, page-46
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.27 |
Change
0.000(0.00%) |
Mkt cap ! $97.17M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 292 | $6.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.30 | 563 | 2 |
View Market Depth
| Last trade - 10.34am 30/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable